Lilly to acquire Centessa for $6.3 billion to expand sleep disorder treatments
Tweet Send to a Friend
Eli Lilly and Company (NYSE: LLY) announced a definitive agreement to acquire Centessa Pharmaceuticals plc (NASDAQ: CNTA) for $38.00 per ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
